JP2021502362A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502362A5 JP2021502362A5 JP2020524855A JP2020524855A JP2021502362A5 JP 2021502362 A5 JP2021502362 A5 JP 2021502362A5 JP 2020524855 A JP2020524855 A JP 2020524855A JP 2020524855 A JP2020524855 A JP 2020524855A JP 2021502362 A5 JP2021502362 A5 JP 2021502362A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- international publication
- international
- document
- publication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762583403P | 2017-11-08 | 2017-11-08 | |
| US62/583,403 | 2017-11-08 | ||
| PCT/US2018/059906 WO2019094650A1 (en) | 2017-11-08 | 2018-11-08 | Fulvestrant formulations and methods of their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021502362A JP2021502362A (ja) | 2021-01-28 |
| JP2021502362A5 true JP2021502362A5 (https=) | 2021-09-24 |
| JP7220712B2 JP7220712B2 (ja) | 2023-02-10 |
Family
ID=64650494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524855A Active JP7220712B2 (ja) | 2017-11-08 | 2018-11-08 | フルベストラント製剤とその使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12186427B2 (https=) |
| EP (1) | EP3706719A1 (https=) |
| JP (1) | JP7220712B2 (https=) |
| KR (1) | KR102670293B1 (https=) |
| CN (1) | CN111479556B (https=) |
| AU (1) | AU2018366212B2 (https=) |
| BR (1) | BR112020009141A2 (https=) |
| CO (1) | CO2020006951A2 (https=) |
| IL (1) | IL274433B2 (https=) |
| MA (1) | MA50570A (https=) |
| MX (2) | MX2020004792A (https=) |
| MY (1) | MY204442A (https=) |
| UA (1) | UA128158C2 (https=) |
| WO (1) | WO2019094650A1 (https=) |
| ZA (1) | ZA202002897B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4074304A4 (en) * | 2019-12-11 | 2024-01-10 | Shanghai Bocimed Pharmaceutical Co., Ltd. | PHARMACEUTICAL COMPOSITION OF FULVESTRANT, PREPARATION METHOD AND APPLICATION THEREOF |
| CN120284882A (zh) * | 2020-12-10 | 2025-07-11 | 上海云晟研新生物科技有限公司 | 氟维司群药物组合物、其制备方法及应用 |
| JP2024545690A (ja) * | 2021-12-20 | 2024-12-10 | サムヤン、ホールディングス、コーポレーション | 溶解度が改善されたフルベストラントの医薬組成物及びその製造方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
| US6495534B2 (en) | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
| PL367624A1 (en) | 2001-07-07 | 2005-03-07 | Astrazeneca Ab | Pharmaceutical formulation for the intramuscular administration of fulvestrant |
| CA2575906C (en) | 2004-08-04 | 2014-04-15 | Camurus Ab | Compositions forming non-lamellar dispersions |
| JP2006089386A (ja) * | 2004-09-21 | 2006-04-06 | Nippon Tenganyaku Kenkyusho:Kk | ステロイドまたはステロイド誘導体を含有する懸濁性医薬組成物 |
| CN1857217A (zh) * | 2006-03-28 | 2006-11-08 | 济南康泉医药科技有限公司 | 一种含雌激素受体拮抗剂的抗癌缓释注射剂 |
| CN101244029A (zh) * | 2006-03-28 | 2008-08-20 | 济南康泉医药科技有限公司 | 含雌激素受体拮抗剂的抗癌缓释注射剂 |
| JP2011514349A (ja) * | 2008-03-07 | 2011-05-06 | サイドース・エルエルシー | フルベストラント配合物 |
| CN101525364B (zh) | 2008-03-07 | 2012-12-12 | 杭州九源基因工程有限公司 | 一种氟维司群的晶型及其制备方法 |
| WO2011022861A1 (zh) | 2009-08-31 | 2011-03-03 | 西安力邦医药科技有限责任公司 | 氟维司群纳米球/微球及其制备方法和用途 |
| WO2011011978A1 (zh) * | 2009-07-31 | 2011-02-03 | 西安力邦医药科技有限责任公司 | 微球药物载体、其制备方法、组合物及应用 |
| CN103221052A (zh) | 2010-09-16 | 2013-07-24 | 施摩达生物技术有限公司 | 氟维司群组合物及使用方法 |
| EP2711010B1 (en) | 2011-05-20 | 2018-10-31 | Capital, Business Y Gestión De Finanzas, S.L | Pharmaceutical composition |
| CA2869377C (en) * | 2012-04-09 | 2022-11-08 | Scidose, Llc | Fulvestrant formulations |
| WO2013182668A1 (en) | 2012-06-08 | 2013-12-12 | F. Hoffmann-La Roche Ag | Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer |
| CN104782169B (zh) * | 2013-07-08 | 2019-06-28 | 华为技术有限公司 | 视频播放的控制方法、设备及系统 |
| CN104337761B (zh) * | 2013-08-07 | 2019-03-26 | 江苏豪森药业集团有限公司 | 氟维司群药物组合物 |
| WO2015033302A2 (en) * | 2013-09-06 | 2015-03-12 | Salah Uddin Ahmed | Fulvestrant compositions |
| IL285928B2 (en) | 2016-05-06 | 2025-06-01 | Eagle Pharmaceuticals Inc | Fulvestrant formulations and methods of their use |
| US11590077B2 (en) * | 2016-05-06 | 2023-02-28 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations and methods of their use |
-
2018
- 2018-11-08 EP EP18815404.1A patent/EP3706719A1/en active Pending
- 2018-11-08 MY MYPI2020002279A patent/MY204442A/en unknown
- 2018-11-08 MX MX2020004792A patent/MX2020004792A/es unknown
- 2018-11-08 KR KR1020207015889A patent/KR102670293B1/ko active Active
- 2018-11-08 BR BR112020009141-3A patent/BR112020009141A2/pt unknown
- 2018-11-08 IL IL274433A patent/IL274433B2/en unknown
- 2018-11-08 WO PCT/US2018/059906 patent/WO2019094650A1/en not_active Ceased
- 2018-11-08 MA MA050570A patent/MA50570A/fr unknown
- 2018-11-08 UA UAA202003420A patent/UA128158C2/uk unknown
- 2018-11-08 CN CN201880080066.2A patent/CN111479556B/zh active Active
- 2018-11-08 AU AU2018366212A patent/AU2018366212B2/en active Active
- 2018-11-08 JP JP2020524855A patent/JP7220712B2/ja active Active
-
2020
- 2020-05-18 ZA ZA2020/02897A patent/ZA202002897B/en unknown
- 2020-06-05 CO CONC2020/0006951A patent/CO2020006951A2/es unknown
- 2020-07-13 MX MX2024010323A patent/MX2024010323A/es unknown
-
2023
- 2023-02-14 US US18/109,421 patent/US12186427B2/en active Active